User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus

  1. Abate-Shen C., Molecular genetics of prostate cancer, 10.1101/gad.819500
  2. Baylin Stephen B, Herman James G, DNA hypermethylation in tumorigenesis: epigenetics joins genetics, 10.1016/s0168-9525(99)01971-x
  3. Bea S, Cancer Res., 61, 2409 (2001)
  4. Bernard David, Pourtier-Manzanedo Albin, Gil Jesús, Beach David H., Myc confers androgen-independent prostate cancer cell growth, 10.1172/jci200319035
  5. Bracken A. P., EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, 10.1093/emboj/cdg542
  6. Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., Jones R. S., Zhang Y., Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing, 10.1126/science.1076997
  7. Carroll AG, Prostate, 23, 123 (1993)
  8. Chi SG, Clin. Cancer Res., 3, 1889 (1997)
  9. Drayton Sarah, Rowe Janice, Jones Rebecca, Vatcheva Radost, Cuthbert-Heavens Darren, Marshall John, Fried Mike, Peters Gordon, Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes, 10.1016/s1535-6108(03)00242-3
  10. Feldman Brian J., Feldman David, The development of androgen-independent prostate cancer, 10.1038/35094009
  11. Francis Nicole J., Kingston Robert E., Mechanisms of transcriptional memory, 10.1038/35073039
  12. Futreal P. Andrew, Coin Lachlan, Marshall Mhairi, Down Thomas, Hubbard Timothy, Wooster Richard, Rahman Nazneen, Stratton Michael R., A census of human cancer genes, 10.1038/nrc1299
  13. Gil Jesús, Bernard David, Martínez Dolores, Beach David, Polycomb CBX7 has a unifying role in cellular lifespan, 10.1038/ncb1077
  14. Hanahan Douglas, Weinberg Robert A, The Hallmarks of Cancer, 10.1016/s0092-8674(00)81683-9
  15. Hudson DL, Lab. Invest., 80, 1243 (2000)
  16. Jacobs Jacqueline J.L., van Lohuizen Maarten, Polycomb repression: from cellular memory to cellular proliferation and cancer, 10.1016/s0304-419x(02)00052-5
  17. Jones Peter A, DNA methylation and cancer, 10.1038/sj.onc.1205597
  18. Kanno M, EMBO J., 14, 5672 (1995)
  19. Kasibhatla Shailaja, Brunner Thomas, Genestier Laurent, Echeverri Fernando, Mahboubi Artin, Green Douglas R, DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1, 10.1016/s1097-2765(00)80054-4
  20. Kirmizis A, Mol. Cancer Ther., 2, 113 (2003)
  21. Kirmizis A., Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27, 10.1101/gad.1200204
  22. Kleer C. G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S. A., Ghosh D., Sewalt R. G. A. B., Otte A. P., Hayes D. F., Sabel M. S., Livant D., Weiss S. J., Rubin M. A., Chinnaiyan A. M., EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, 10.1073/pnas.1933744100
  23. Kuzmichev A., Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein, 10.1101/gad.1035902
  24. Lessard Julie, Sauvageau Guy, Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells, 10.1038/nature01572
  25. Lu S, Cancer Res., 57, 4511 (1997)
  26. Lund Anders H, van Lohuizen Maarten, Polycomb complexes and silencing mechanisms, 10.1016/j.ceb.2004.03.010
  27. Muyrers-Chen Inhua, Paro Renato, Epigenetics: unforeseen regulators in cancer, 10.1016/s0304-419x(01)00032-4
  28. Nelson William G., De Marzo Angelo M., Isaacs William B., Prostate Cancer, 10.1056/nejmra021562
  29. Nupponen Nina N., Kakkola Laura, Koivisto Pasi, Visakorpi Tapio, Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas, 10.1016/s0002-9440(10)65554-x
  30. Otte Arie P, Kwaks Ted HJ, Gene repression by Polycomb group protein complexes: a distinct complex for every occasion?, 10.1016/s0959-437x(03)00108-4
  31. Pasini Diego, Bracken Adrian P., Helin Kristian, Polycomb Group Proteins in Cell Cycle Progression and Cancer, 10.4161/cc.3.4.773
  32. Porkka Kati P, Visakorpi Tapio, Molecular Mechanisms of Prostate Cancer, 10.1016/j.eururo.2004.01.012
  33. Raaphorst Frank M., van Kemenade Folkert J., Blokzijl Tjasso, Fieret Elly, Hamer Karien M., Satijn David P.E., Otte Arie P., Meijer Chris J.L.M., Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease, 10.1016/s0002-9440(10)64583-x
  34. Satijn D P, Olson D J, van der Vlag J, Hamer K M, Lambrechts C, Masselink H, Gunster M J, Sewalt R G, van Driel R, Otte A P, Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis., 10.1128/mcb.17.10.6076
  35. Tokimasa S, Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage, 10.1016/s0301-472x(00)00620-2
  36. van Kemenade F. J., Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma, 10.1182/blood.v97.12.3896
  37. Varambally Sooryanarayana, Dhanasekaran Saravana M., Zhou Ming, Barrette Terrence R., Kumar-Sinha Chandan, Sanda Martin G., Ghosh Debashis, Pienta Kenneth J., Sewalt Richard G. A. B., Otte Arie P., Rubin Mark A., Chinnaiyan Arul M., The polycomb group protein EZH2 is involved in progression of prostate cancer, 10.1038/nature01075
  38. Visakorpi Tapio, The molecular genetics of prostate cancer, 10.1016/s0090-4295(03)00776-3
  39. Visakorpi T, Cancer Res., 55, 342 (1995)
  40. Visser Hein P. J., Gunster Marco J., Kluin-Nelemans Hanneke C., Manders Erik M. M., Raaphorst Frank M., Meijer Chris J. L. M., Willemze Roel, Otte Arie P., The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma, 10.1046/j.1365-2141.2001.02641.x
  41. Wang J, Genes Dev., 12, 1769 (1998)
  42. Wang Liangjun, Brown J.Lesley, Cao Ru, Zhang Yi, Kassis Judith A, Jones Richard S, Hierarchical Recruitment of Polycomb Group Silencing Complexes, 10.1016/j.molcel.2004.05.009
  43. Zindy F, Genes Dev., 12, 2424 (1998)
Bibliographic reference Bernard, D ; Martinez-Leal, JF ; Rizzo, S ; Martinez, D ; Hudson, D ; et. al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. In: Oncogene : including Oncogene Reviews, Vol. 24, no. 36, p. 5543-5551 (2005)
Permanent URL http://hdl.handle.net/2078.1/39156